EDGAR Filing Documents for 0001354488-15-003110

Form 8-K - Current report:

SEC Accession No. 0001354488-15-003110

Filing Date

2015-06-22

Accepted

2015-06-22 17:00:36

Documents

Period of Report

2015-06-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	tbuff_8k.htm	8-K	75172
2	SHARE PURCHASE AGREEMENT	tbuff_ex11.htm	EX-1.1	629408
3	AGENCY AGREEMENT	tbuff_ex12.htm	EX-1.2	284345
4	PROMISSORY NOTE	tbuff_ex41.htm	EX-4.1	63438
5	FORM OF DEBENTURE	tbuff_ex42.htm	EX-4.2	196483
6	PRESS RELEASE	tbuff_ex991.htm	EX-99.1	36098
7		tribute.jpg	GRAPHIC	9147
	Complete submission text file	0001354488-15-003110.txt		1299261

Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8

Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540

Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)